BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34225249)

  • 1. Validity of chemotherapy information derived from routinely collected healthcare data: A national cohort study of colon cancer patients.
    Boyle JM; Kuryba A; Braun MS; Aggarwal A; van der Meulen J; Cowling TE; Walker K
    Cancer Epidemiol; 2021 Aug; 73():101971. PubMed ID: 34225249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England.
    Gannon MR; Park MH; Miller K; Dodwell D; Horgan K; Clements K; Medina J; Cromwell DA
    Cancer Epidemiol; 2023 Apr; 83():102337. PubMed ID: 36774694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of recording of chemotherapy cycles in the National Cancer Registration and Analysis Service Systemic Anti-Cancer Therapy database and the Hospital Episode Statistics Admitted Patient Care database.
    McDonald L; Sammon C; Carroll R; Harish A; C AS; Tyas D; Ramagopalan SV
    Future Oncol; 2020 Jan; 16(3):4455-4460. PubMed ID: 31820657
    [No Abstract]   [Full Text] [Related]  

  • 4. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
    Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a coding framework to identify severe acute toxicity from systemic anti-cancer therapy using hospital administrative data.
    Boyle JM; Cowling TE; Kuryba A; Fearnhead NS; van der Meulen J; Braun MS; Walker K; Aggarwal A
    Cancer Epidemiol; 2022 Apr; 77():102096. PubMed ID: 35030349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England.
    Bouras G; Burns EM; Howell AM; Bottle A; Athanasiou T; Darzi A
    PLoS One; 2015; 10(12):e0145759. PubMed ID: 26713434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
    Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
    Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohort profile: radiotherapy dataset (RTDS) in England.
    Sandhu S; Sharpe M; Findlay Ú; Roe C; Broggio J; Spencer K; Thackray K
    BMJ Open; 2023 Jun; 13(6):e070699. PubMed ID: 37339842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
    Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J
    Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking maternity data for England, 2005-06: methods and data quality.
    Dattani N; Datta-Nemdharry P; Macfarlane A
    Health Stat Q; 2011; (49):53-79. PubMed ID: 21372845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the prescription of systemic anticancer therapy and mortality among patients with advanced non-small cell lung cancer: a real-world retrospective observational cohort study from the I-O optimise initiative.
    Snee M; Cheeseman S; Thompson M; Riaz M; Sopwith W; Lacoin L; Chaib C; Manley Daumont M; Penrod JR; O'Donnell JC; Hall G
    BMJ Open; 2021 May; 11(5):e043442. PubMed ID: 33941627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.
    Eheman CR; O'Neil ME; Styles TS; Thompson TD; Morris CR; Babcock FA; Chen VW
    J Registry Manag; 2016; 43(4):179-186. PubMed ID: 29308117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National administrative data produces an accurate and stable risk prediction model for short-term and 1-year mortality following cardiac surgery.
    Aktuerk D; McNulty D; Ray D; Begaj I; Howell N; Freemantle N; Pagano D
    Int J Cardiol; 2016 Jan; 203():196-203. PubMed ID: 26512837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine.
    Tashiro J; Yamaguchi S; Ishii T; Kondo H; Hara K; Shimizu H; Takemoto K; Suzuki A
    Clin Colorectal Cancer; 2017 Sep; 16(3):e141-e145. PubMed ID: 28216247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
    McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
    Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
    Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
    J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.